Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis

Deloire, M. S. A.; Salort, E.; Bonnet, M.; Arimone, Y.; Boudineou, M.; Amieva, H.; Barroso, B.; Ouallet, J-C.; Pachai, C.; Galliaud, E.; Pefry, K. G.; Dousset, V.; Fabrigoule, C.; Brochet, B.
April 2005
Journal of Neurology, Neurosurgery & Psychiatry;Apr2005, Vol. 76 Issue 4, p519
Academic Journal
Objectives: To establish the frequency of cognitive impairment in a population based sample of patients with recently diagnosed relapsing-remitting multiple sclerosis (RRMS), and to determine the relation between cognitive abnormalities and the extent of macroscopic and microscopic tissue damage revealed by magnetic resonance imaging (MRI) and magnetisation transfer (MT) imaging. Methods: 58 patients with RRMS consecutively diagnosed in the previous six months in Aquitaine and 70 healthy controls underwent a battery of neuropsychological tests. Lesion load and atrophy indices (brain parenchymal fraction and ventricular fraction) were measured on brain MRI. MT ratio (FAIR) histograms were obtained from lesions, normal appearing white matter (NAWM), and normal appearing grey matter (NAGM). Gadolinium enhanced lesions were counted. Results: 44 RRMS patients could be individually matched with healthy controls For age, sex, and education. Patients performed worse in tests of verbal and spatial memory, attention, information processing speed, inhibition, and conceptualisation. Measures of attention and information processing speed were correlated with lesion load, mean NAWM MTR, and the peak location of the NAGM MTR histogram in the patients. Multivariate regression analysis showed that lesion load and mean NAWM MTR were among the MR indices that were most significantly associated with impairment of attention and information processing speed in these early RRMS cases. Conclusions: Cognitive impairment appears to be common in the early stages of RRMS, mainly affecting attention, information processing speed, memory, inhibition, and conceptualisation. The severity of these deficits reflects the extent of the lesions and the severity of tissue disorganisation outside lesions.


Related Articles

  • Discriminant analysis of the cognitive performance profile of MS patients differentiates their clinical course. Kraus, Jürgen; Schütze, Cathleen; Brokate, Barbara; Kröger, Beate; Schwendemann, Günther; Hildebrandt, Helmut // Journal of Neurology;Jul2005, Vol. 252 Issue 7, p808 

    Objective To compare the neuropsychological deficits of primary progressive multiple sclerosis with those of relapsing-remitting and secondary progressive multiple sclerosis. Methods Sixty-five patients with different clinical courses of MS were neuropsychologically tested for language,...

  • Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis. Benešová, Y.; Vašků, A.; Novotná, H.; Litzman, J.; Štourač, P.; Beránek, M.; Kadańka, Z.; Bednařík, J. // Multiple Sclerosis (13524585);Mar2009, Vol. 15 Issue 3, p316 

    Background Matrix metalloproteinases are notable contributors to neuroinflammation and bloodbrain barrier disruption in multiple sclerosis (MS). Objective The goal of this study was to determine the serum levels of matrix metalloproteinase-9 (MMP-9), matrix metalloproteinase-2 (MMP-2), and their...

  • How to detect cognitive dysfunction at early stages of multiple sclerosis? Deloire, M. S. A.; Bonnet, M. C.; Salort, E.; Arimone, Y.; Boudineau, M.; Petry, K. G.; Brochet, B. // Multiple Sclerosis (13524585);Aug2006, Vol. 12 Issue 4, p445 

    Detecting cognitive dysfunction may be clinically important during the early stages of multiple sclerosis (MS). We assessed a self-report questionnaire on cognitive complaints and individual neuropsychological tests to select patients with early relapsing-remitting MS (RRMS) who needed...

  • Cognitive dysfunction in patients with relapsing-remitting multiple sclerosis. Nocentini, U.; Pasqualetti, P.; Bonavita, S.; Buccafusca, M.; de Caro, M. F.; Farina, D.; Girlanda, P.; Le Pira, F.; Lugaresi, A.; Quattrone, A.; Reggio, A.; Salemi, G.; Savettieri, G.; Tedeschi, G.; Trojano, M.; Valentino, P.; Caltagirone, C. // Multiple Sclerosis (13524585);Feb2006, Vol. 12 Issue 1, p77 

    Cognitive dysfunction is considered one of the clinical markers of multiple sclerosis (MS). However, in the literature there are inconsistent reports on the prevalence of cognitive dysfunction, and separate data for the relapsing-remitting (RR) type of the disease are not always presented. In...

  • Cognitive dysfunction 24-31 years after isolated optic neuritis. Nilsson, P.; Rorsman, I.; Larsson, E. M.; Norrving, B.; Sandberg-Wollheim, M. // Multiple Sclerosis (13524585);Aug2008, Vol. 14 Issue 7, p913 

    Objective Cognitive dysfunction is common in multiple sclerosis (MS), but long-term data on cognition in patients with clinically isolated syndromes are sparse. Methods We determined cognitive functions in 22 patients 44-75 years old diagnosed with optic neuritis 24-31 years earlier but had no...

  • Frequency of cognitive impairment dramatically increases during the first 5 years of multiple sclerosis. Reuter, Franc¸oise; Zaaraoui, Wafaa; Crespy, Lydie; Faivre, Anthony; Rico, Audrey; Malikova, Irina; Soulier, Elisabeth; Viout, Patrick; Ranjeva, Jean-Philippe; Pelletier, Jean; Audoin, Bertrand // Journal of Neurology, Neurosurgery & Psychiatry;Oct2011, Vol. 82 Issue 10, p1157 

    Previous studies have demonstrated that cognitive impairment is already present in patients suffering from a clinically isolated syndrome (CIS) suggestive of multiple sclerosis (MS). However, little is known about the course of cognitive impairment after the occurrence of a CIS. In order to...

  • INFLAMMATORY/POST-INFECTIOUS ENCEPHALOMYELITIS. Bennetto, L; Scolding, N // Journal of Neurology, Neurosurgery & Psychiatry;Mar2004 Supplement 1, Vol. 75, pi22 

    Post-infectious and inflammatory encephalomyelitis are broadly represented by the syndrome acute disseminated encephalomyelitis (ADEM). ADEM forms one of several categories of primary inflammatory demyelinating disorders of the central nervous system. Others include multiple sclerosis (MS),...

  • Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis. Fenoglio, Chiara; Ridolfi, Elisa; Cantoni, Claudia; De Riz, Milena; Bonsi, Rossana; Serpente, Maria; Villa, Chiara; Pietroboni, Anna M; Naismith, Robert T; Alvarez, Enrique; Parks, Becky J; Bresolin, Nereo; Cross, Anne H; Piccio, Laura M; Galimberti, Daniela; Scarpini, Elio // Multiple Sclerosis Journal;Dec2013, Vol. 19 Issue 14, p1938 

    Emerging evidence underlines the importance of micro(mi)RNAs in the pathogenesis of multiple sclerosis (MS). Free-circulating miRNAs were investigated in serum from MS patients compared to controls. Statistically significant decreased levels of miR-15b, miR-23a and miR-223 were observed in MS...

  • Differential microRNA expression in blood in multiple sclerosis. Søndergaard, Helle Bach; Hesse, Dan; Krakauer, Martin; Sørensen, Per Soelberg; Sellebjerg, Finn // Multiple Sclerosis Journal;Dec2013, Vol. 19 Issue 14, p1849 

    The article presents information on differential microRNA (miRNA) expression in blood in patients with multiple sclerosis (MS). It states that genome expression is regulated by miRNAs at the post transcriptional level in MS patients. It also analyses the utility of miRNAs in MS as diagnostic...


Read the Article


Sign out of this library

Other Topics